As of 2025-03-18, the EV/EBITDA ratio of Reata Pharmaceuticals Inc (RETA) is -15.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RETA's latest enterprise value is 5,813.45 mil USD. RETA's TTM EBITDA according to its financial statements is -378.12 mil USD. Dividing these 2 quantities gives us the above RETA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 11.6x | 9.6x |
| Forward P/E multiples | 9.5x - 17.0x | 12.8x |
| Fair Price | (107.22) - (131.31) | (127.37) |
| Upside | -162.2% - -176.2% | -173.9% |
| Date | EV/EBITDA |